4.8 Article

Topoisomerase IIα controls the decatenation checkpoint

Journal

NATURE CELL BIOLOGY
Volume 11, Issue 2, Pages 204-U196

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/ncb1828

Keywords

-

Categories

Funding

  1. National Institutes of Health (NIH)
  2. Richard Schulze Family Foundation
  3. Susan G. Komen Breast Cancer Foundation
  4. NIH [CA130996]
  5. Department of Defense,
  6. Mayo Clinic Breast SPORE

Ask authors/readers for more resources

Topoisomerase II (Topo II) is required to separate intertwined sister chromatids before chromosome segregation can occur in mitosis(1). However, it remains to be resolved whether Topo II has any role in checkpoint control. Here we report that when phosphorylated, Ser 1524 of Topo II alpha acts as a binding site for the BRCT domain of MDC1 (mediator of DNA damage checkpoint protein-1), thereby recruiting MDC1 to chromatin. Although Topo II alpha-MDC1 interaction is not required for checkpoint activation induced by DNA damage, it is required for activation of the decatenation checkpoint. Mutation of Ser 1524 results in a defective decatenation checkpoint. These results reveal an important role of Topo II in checkpoint activation and in the maintenance of genomic stability.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available